CAS: 357336-20-0 - 2(S)-[2-Oxo-4(R)-propylpyrrolidin-1-yl]butyramide
Formula:C11H20N2O2
InChI:InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1
InChI key:InChIKey=MSYKRHVOOPPJKU-BDAKNGLRSA-N
SMILES:O=C(N)C(N1C(=O)CC(C1)CCC)CC
- Synonyms:
- (2S)-2-[(4R)-2-Oxo-4-propyl-1-pyrrolidinyl]butanamide
- (alphaS,4R)-alpha-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
- (αS,4R)-α-Ethyl-2-oxo-4-propyl-1-pyrrolidineacetamide
- 1-Pyrrolidineacetamide α-ethyl-2-oxo-4-propyl-, (αS,4R)-
- Brivaracetam
- Briviact
- Ucb-34714
Ref: 41-Y0002407
160mg | 455.00 € |
Estimated delivery in United States, on Tuesday 30 Apr 2024
Brivaracetam
CAS:357336-20-0
Formula:
C11H20N2O2
Color and Shape:
White To Off-White Solid
Molecular weight:
212.29
Ref: 4Z-B-105001
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | 974.00 € |
Estimated delivery in United States, on Friday 3 May 2024
Brivaracetam
Controlled ProductCAS:357336-20-0
Applications Brivaracetam, is a 4-n-propyl analog of levetiracetam (L331500), and a racetam derivative with anticonvulsant …
Formula:
C11H20N2O2
Color and Shape:
Off-White
Molecular weight:
212.29
Ref: TR-B677645
10mg | 276.00 € | |
25mg | 330.00 € | |
100mg | 889.00 € |
Estimated delivery in United States, on Tuesday 14 May 2024
Brivaracetam
Controlled ProductCAS:357336-20-0
Binds to synaptic vesicle protein SV2A; analog of levetiracetam; anti-epileptic
Formula:
C11H20N2O2
Purity:
Min. 95%
Color and Shape:
White Powder
Molecular weight:
212.29 g/mol
Ref: 3D-BB161996
10mg | 188.00 € | |
25mg | 281.00 € | |
50mg | 474.00 € | |
100mg | 714.00 € | |
250mg | 1,144.00 € |
Estimated delivery in United States, on Monday 13 May 2024